BCL2 inhibition: back to the future!

Blood. 2024 May 2;143(18):1787-1788. doi: 10.1182/blood.2023023796.
No abstract available

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Apoptosis / drug effects
  • Humans
  • Proto-Oncogene Proteins c-bcl-2* / antagonists & inhibitors
  • Proto-Oncogene Proteins c-bcl-2* / metabolism

Substances

  • Proto-Oncogene Proteins c-bcl-2
  • Antineoplastic Agents
  • BCL2 protein, human